IP Library Granted Patent US 12,188,078
Granted Patent B2
US 12,188,078 · App. 17/447,794 · Granted Jan 7, 2025

Methods for preparing a sample for nucleic acid amplification using tagmentation

Inventors: Louise Fraser (Cambridge, GB); Paula Kokko-Gonzales (Cambridge, GB); Andrew Slatter (Cambridge, GB)
Assignee: Illumina Cambridge Limited
C12Q1/6806C12N15/1003C12P19/34C12Q1/6846
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,188,078
App. No.
17/447,794
Granted
Jan 7, 2025
Kind
B2
Abstract

Presented are methods and compositions for preparing samples for amplification and sequencing. Particular embodiments relate to methods of preparing nucleic acid containing cellular samples for library amplification, wherein the methods include lysing cells of the sample to form a lysate, amplifying the nucleic acids from the lysed samples, wherein there is no purification of the nucleic acids from the lysate prior to the amplification, wherein amplifying comprises tagmentation, and sequencing the nucleic acids, wherein the sample is a blood sample or a formalin-fixed paraffin-embedded (FFPE) sample.

Claims (23)

1. A method of sequencing nucleic acids from a cellular sample, comprising:

lysing cells from a nucleic acid-containing cellular sample with a lysis reagent to form a lysate of nucleic acids;

amplifying the nucleic acids in the lysate wherein there is no purification of the nucleic acids from the lysate prior to the amplification, wherein amplifying comprises tagmentation; and

sequencing the nucleic acids,

wherein the sample is a blood sample or a formalin-fixed paraffin-embedded (FFPE) sample.

2. The method of claim 1 , wherein the FFPE sample is a tissue sample, a biopsy, or an aspirate.

3. The method of claim 1 , wherein the sample is a tumor sample.

4. The method of claim 1 , wherein the blood sample is a whole blood sample or a dried blood sample.

5. The method of claim 1 , wherein the nucleic acid is DNA.

6. The method of claim 1 , wherein the lysis reagent is water, purified water, or distilled water.

7. The method of claim 1 , wherein the lysis reagent is a detergent, a non-denaturing lytic detergent, a base, an acid, and/or an enzyme.

8. The method of claim 7 , wherein the lysis reagent comprises a reducing agent, stabilizing agent, 2-mercaptoethanol, or dithiothreitol.

9. The method of claim 1 , wherein the amplifying comprises treating the cells of the sample or the lysate with an enzyme that disrupts the structure of the nucleic acid.

10. The method of claim 9 , wherein the enzyme that disrupts the structure of the nucleic acid is proteinase K.

11. The method of claim 1 , further comprising neutralizing the lysis reagent prior to the amplification step to inactivate the lysis reagent.

12. The method of claim 1 , wherein the steps of lysing the sample and amplifying the nucleic acid contained in the lysate are conducted in a single pot reaction.

13. The method of claim 1 , wherein sequencing comprises high throughput sequencing or sequence-by-synthesis.

14. The method of claim 1 , wherein the tagmentation is performed using bead-based tagmentation.

15. The method of claim 14 , wherein the tagmentation comprises fragmenting the nucleic acid in the lysate.

16. The method of claim 1 , wherein the lysate of nucleic acids further comprises components from the FFPE sample.

17. The method of claim 16 , wherein the FFPE components are selected from the group consisting of formalin, paraffin, cellular components, protein, extracellular matrix components, collagen, and tissue debris.

18. The method of claim 17 , wherein the amplifying step is performed in the presence of at least 0.01 pg, at least 0.1 pg, at least 1 pg, at least 10 pg, at least 100 pg, at least 1 ng, at least 10 ng, at least 100 ng, at least 1 μg, at least 10 μg, at least 100 μg, or at least 1 mg paraffin.

19. The method of claim 17 , wherein the amplifying step is performed in the presence of at least 0.001 pg paraffin.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2021
From: FRASER, LOUISE; KOKKO-GONZALES, PAULA; SLATTER, ANDREW
To: ILLUMINA CAMBRIDGE LIMITED
Reel/Frame 057805/0404 →
Priority Claims (2)
GB 1410196 · Jun 9, 2014 · national
GB 1412207 · Jul 9, 2014 · national
Continuity (6)
Continuation 17005128 · Aug 27, 2020
Continuation 16163005 · Oct 17, 2018
Continuation 14733452 · Jun 8, 2015
Provisional Application 62171814 · Jun 5, 2015
Provisional Application 62171908 · Jun 5, 2015
Related Publication 20220002783A1 · Jan 6, 2022
References Cited (48)
US 8728764B2 · Boutell · 2014 [cited by applicant]
US 8771951B2 · Hogan · 2014 [cited by applicant]
US 10017759B2 · Kaper et al. · 2018 [cited by applicant]
US 20060099627A1 · Kara et al. · 2006 [cited by applicant]
US 20080108515A1 · Gormley et al. · 2008 [cited by applicant]
US 20080242555A1 · Shen et al. · 2008 [cited by applicant]
US 20090042290A1 · Steele et al. · 2009 [cited by applicant]
US 20110236891A1 · Li et al. · 2011 [cited by applicant]
US 20120122737A1 · Sabot et al. · 2012 [cited by applicant]
US 20130065223A1 · Klein et al. · 2013 [cited by applicant]
US 20150087534A1 · Gormley et al. · 2015 [cited by applicant]
US 20150337298A1 · Xi et al. · 2015 [cited by applicant]
US 20180104690A1 · Blainey et al. · 2018 [cited by applicant]
CN 102344919 · 2012 [cited by applicant]
CN 103710323 · 2014 [cited by applicant]
EP 2388312 · 2011 [cited by applicant]
WO WO2009016652 · 2009 [cited by applicant]
WO WO2010038042 · 2010 [cited by applicant]
WO WO2011025477 · 2011 [cited by applicant]
WO WO2011104027A1 · 2011 [cited by applicant]
WO WO2012034030 · 2012 [cited by applicant]
WO WO2013131962 · 2013 [cited by applicant]
WO WO2015189588 · 2015 [cited by applicant]
WO WO2017006108 · 2017 [cited by applicant]
Cawkwell et al., “Short report Direct multiplex amplification of DNA from a formalin fixed, paraYn wax embedded tissue section”, Feb. 1, 2000 (Feb. 1, 2000), XP055713511, Retrieved from the Internet: URL:https://www.ncb… [cited by applicant]
Dedhia et al., “Evaluation of DNA extraction methods and real time PCR optimization on formalin-fixed paraffin-embedded tissues”, Asian Pacific Journal of Cancer Prevention, TH, vol. 8, No. 1, Jan. 1, 2007 (Jan. 1, 2007… [cited by applicant]
Extended Search Report issued in EP application No. 22165243.1, dated Jul. 13, 2022. [cited by applicant]
Rautio et al. (J Microbiol Methods, 2006, vol. 65:404-416). [cited by applicant]
Uitdewilligen et al. (PLoS one, 2013, 8(5):e62355, p. 1-14). [cited by applicant]
Agilent Technologies, SureDirect Blood PCR Kit: Protocol, 2014. [cited by applicant]
April et al., Whole-Genome Gene Expression Profiling of Formalin-Fixed Paraffin-Embedded Tissue Samples, PLOS One 2009, 4(12), e8162. [cited by applicant]
Chacon-Cortes, Diego et al., “Comparison of genomic DNA, 'K.R.H/ extraction techniques from whole blood samples: a time, cost and quality evaluation study”, Molecular Biology Reports; an International Journal on Molecul… [cited by applicant]
Fedick et al., High-throughput real-time PCR-based genotyping without DNA purification, BMS Research Notes, Biomed Central Ltd., GB, 2012, 5(1), 573. [cited by applicant]
Goldenberger, D. et al., “Technical A Simple “Universal” DNA Extraction Procedure Using SOS and Proteinase K Is Compatible with Direct PCR Amplification”, Genome Res, 1995, 4, 368-370. [cited by applicant]
Herraez-Hernandez et al., Detection and Genotyping of Human Papillomavirus DNA in Formalin-Fixed Paraffin-Embedded Specimens with the HPV Direct Flow CHIP System, Open Virol J, 2013, 7, 91-95. [cited by applicant]
International Search Report and Written Opinion for Application No. PCT/GB2015/051674, mailed Jul. 30, 2015. [cited by applicant]
Kanai, et al., “Rapid and simple method for preparation of genomic DNA from easily obtainable clotted blood”, Journal of Clinical Pathology, vol. 47, No. 11, Nov. 1, 1994, 1043-1044. [cited by applicant]
Park et al., Detection of Hepatitis C Virus RNA Using Ligation-Dependent Polymerase Chain Reaction in Formalin-Fixed, Paraffin-Embedded Liver Tissues, Am. J. Pathol. 1996, 149(5), 1485-1491. [cited by applicant]
Park et al., Direct STR Amplification from Whole Blood and Blood- or Saliva-Spotted FTA without DNA Purification, J. Forensic Sci. 2008, 53(2), 335-341. [cited by applicant]
Zhang et al., Direct DNA Amplification of Crude Clinical Samples Using a PCR Enhancer Cocktail and Novel Mutants of Taq, J. Molecular Diagnostics 2010, 12(2), 153-154. [cited by applicant]
Huang Feijun et al., Evidence for common sense, Forensic Experiment Guide, Sichuan University Press, 2010, 24. [cited by applicant]
Hamaguchi et al., Direct reverse transcription-PCR on oligo(dT)-immobilized polypropylene microplates after capturing total mRNA from crude cell lysates, Clinical Chemistry 1998, 44(11), 2256-2263. [cited by applicant]
Wagle et al., High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing, Cancer Discovery 2012, 2, 82-93. [cited by applicant]
Walsh et al., Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing, PNAS 2010, 107(28), 12629-12633. [cited by applicant]
Campa, Jan. 15, 2009, QuickExtract™ FFPE DNA extraction kit from Epicentre Biotechnologies, product revi+A615ew, https://www.biocompare.com/Product-Reviews/40517-QuickExtract-FFPE-DNA-Extraction-Kit-From-Epicentre-Biote… [cited by applicant]
Adey et al., 2010, Rapid, low-input, low-bias construction of shotgun fragment libraries by high-density in vitro transposition, Genome Biology 11:R119, pp. 1-17. [cited by applicant]
Bergval et al., 2012, Combined Species Identification, Genotyping, and Drug Resistance Detection of [cited by applicant]
Liu et al., 2014, Direct qPCR quantification using the Quantifiler® trio DNA quantification kit, Forensic Sci Intl Genet, 13:10-19. [cited by applicant]